This article is available to subscribers. Subscribe now. Already have an account? Sign in

Clinical Implications of Basic ResearchFree Preview

Turbocharging the T Cell to Fight Cancer

List of authors.
  • Andrea Schietinger, Ph.D.

Modified autologous T cells have been successfully used to treat tumors in a small proportion of patients. How can this general approach be used to treat more patients? A recent study of lymphoma, modeled in vitro, points to a potential approach.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the author are available with the full text of this article at NEJM.org.

This article was published on June 1, 2022, at NEJM.org.

Author Affiliations

From the Immunology Program, Memorial Sloan Kettering Cancer Center, New York.

Print Subscriber? Activate your online access.